{{expert|time=2014-10-14T04:17:20+00:00}}

{{medical}}

[[File:Mirtazapine_2D_structure.svg|right]]的化学结构, 其结构有四个[[官能团|原子环]]]]

'''四环抗抑郁药'''（{{lang-en|tetracyclic antidepressants}}，缩写作 TeCAs）是一种在1907s被引入的[[抗抑郁药|抗抑郁药]]。他们是因其[[化学结构|化学结构]]含有四个[[原子环|原子环]]而命名，与[[三环抗抑郁药|三环抗抑郁药]]紧密相关，即含有三个[[原子环|原子环]]。

== 四環抗憂鬱藥清單 ==
如下:
* 已上市
** {{tsl|en|Maprotiline||Maprotiline}} (Deprilept, Ludiomil, Psymion)
** [[米塞林|米塞林]] (Bolvidon, Norval, Tolvon)
** [[米氮平|米氮平]] (Remeron, Avanza, Zispin)
** {{tsl|en|Pirlindole||Pirlindole}} (Pirazidol) — 在俄羅斯使用的四環[[可逆單胺氧化酶A抑制劑|可逆單胺氧化酶A抑制劑]] (RIMA)
** {{tsl|en|Setiptiline||Setiptiline}} (Tecipul)
* 未上市
** {{tsl|en|Aptazapine||Aptazapine}} (CGS-7525A)
** {{tsl|en|Metralindole||Metralindole}} — 一個四環的可逆單胺氧化酶A抑制劑
** {{tsl|en|Esmirtazapine||Esmirtazapine}} (ORG-50,081)
** {{tsl|en|Oxaprotiline||Oxaprotiline}} (C 49-802 BDA)

== 藥理學 ==

=== 結合特性 ===
以下比較四環抗憂鬱藥對各[[結合位點|結合位點]]的[[配體_(生物化學)|親和性]] (K<sub>d</sub> (nM)):<ref name=Goodman>{{cite book|last=Brunton|first=Laurence|title=Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th Edition|year=2011|publisher=McGraw-Hill|location=China|isbn=978-0-07-162442-8|pages=406–410}}</ref><ref name="pmid9537821">{{cite journal | author = Tatsumi M, Groshan K, Blakely RD, Richelson E | title = Pharmacological profile of antidepressants and related compounds at human monoamine transporters | journal = European Journal of Pharmacology | volume = 340 | issue = 2–3 | pages = 249–258 | date = December 1997 | pmid = 9537821 | doi = 10.1016/S0014-2999(97)01393-9 | url = http://linkinghub.elsevier.com/retrieve/pii/S0014-2999(97)01393-9 | access-date = 2016-03-25 | archive-date = 2021-02-24 | archive-url = https://web.archive.org/web/20210224140227/https://linkinghub.elsevier.com/retrieve/pii/S0014-2999(97)01393-9 }}</ref><ref name="pmid3816971">{{cite journal | author = Wander TJ, Nelson A, Okazaki H, Richelson E | title = Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro | journal = European Journal of Pharmacology | volume = 132 | issue = 2–3 | pages = 115–121 |date=December 1986 | pmid = 3816971 | doi = 10.1016/0014-2999(86)90596-0| url = }}</ref><ref name="pmid6086881">{{cite journal | author = Richelson E, Nelson A | title = Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro | journal = The Journal of Pharmacology and Experimental Therapeutics | volume = 230 | issue = 1 | pages = 94–102 | date = July 1984 | pmid = 6086881 | doi =  | url = http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=6086881 | access-date = 2016-03-25 | archive-date = 2021-08-28 | archive-url = https://web.archive.org/web/20210828041010/https://jpet.aspetjournals.org/content/230/1/94.long }}</ref><ref name="pmid10193665">{{cite journal | author = Tatsumi M, Jansen K, Blakely RD, Richelson E | title = Pharmacological profile of neuroleptics at human monoamine transporters | journal = European Journal of Pharmacology | volume = 368 | issue = 2–3 | pages = 277–283 |date=March 1999 | pmid = 10193665 | doi = 10.1016/S0014-2999(99)00005-9| url = }}</ref><ref name="pmid2891550">{{cite journal | author = Wander TJ, Nelson A, Okazaki H, Richelson E | title = Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro | journal = European Journal of Pharmacology | volume = 143 | issue = 2 | pages = 279–282 | date = November 1987 | pmid = 2891550 | doi = 10.1016/0014-2999(87)90544-9 | url = http://linkinghub.elsevier.com/retrieve/pii/0014-2999(87)90544-9 | access-date = 2016-03-25 | archive-date = 2019-05-17 | archive-url = https://web.archive.org/web/20190517233836/https://linkinghub.elsevier.com/retrieve/pii/0014-2999(87)90544-9 }}</ref><ref name="pmid6149136">{{cite journal | author = Richelson E, Nelson A | title = Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro | journal = European Journal of Pharmacology | volume = 103 | issue = 3–4 | pages = 197–204 |date=August 1984 | pmid = 6149136 | doi = 10.1016/0014-2999(84)90478-3| url = }}</ref><ref name="pmid15771415">{{cite journal  |vauthors=Fernández J, Alonso JM, Andrés JI, etal | title = Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents | journal = Journal of Medicinal Chemistry | volume = 48 | issue = 6 | pages = 1709–12 |date=March 2005 | pmid = 15771415 | doi = 10.1021/jm049632c}}</ref><ref name="pmid3419539">{{cite journal |vauthors = de Boer TH, Maura G, Raiteri M, de Vos CJ, Wieringa J, Pinder RM | title = Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers | journal = Neuropharmacology | volume = 27 | issue = 4 | pages = 399–408 |date=April 1988 | pmid = 3419539 | doi = 10.1016/0028-3908(88)90149-9| url =https://archive.org/details/sim_neuropharmacology_1988-04_27_4/page/399}}</ref>

{| class="wikitable" class="sortable wikitable"
 | '''化合物''' || '''[[Serotonin_transporter|SERT]]''' || '''[[Norepinephrine_transporter|NET]]''' || '''[[Dopamine_transporter|DAT]]''' || '''{{tsl|en|5-HT1A receptor||5-HT<sub>1A</sub>}}''' || '''{{tsl|en|5-HT2A receptor||5-HT<sub>2A</sub>}}''' || '''{{tsl|en|alpha-1 adrenergic receptor||α<sub>1</sub>}}''' || '''{{tsl|en|alpha-2 adrenergic receptor||α<sub>2</sub>}}''' || '''[[D2_receptor|D<sub>2</sub>]]''' || '''{{tsl|en|H1 receptor||H<sub>1</sub>}}''' || '''[[蕈毒鹼型乙醯膽鹼受體|mACh]]'''
 |-
 | {{tsl|en|Amoxapine||Amoxapine}} || 58 || 16.0 || 4,310 || 220 || 0.6 || 50 || 2,600 || 160 || 25 || 1,000
 |-
 | {{tsl|en|Loxapine||Loxapine}} || 2,400 || 380 || 9,000 || 2,900 || 1.7 || 28 || 2,400 || 70 || 4.9 || 450
 |-
 | {{tsl|en|Maprotiline||Maprotiline}} || 5,800 || 11.1 || 1,000 || 12,000 || 120 || 91 || 9,400 || 350 || 2.0 || 560
 |-
 | [[米塞林|米塞林]] || 4,000 || 101 || 9,400 || 190 || 4.3 || 74 || 4.3 || 2,197 || 1.7 || 820
 |-
 | [[米氮平|米氮平]] || >100,000 || 1,640 || >100,000 || ? || 69 || 500 || 19 || >5,454 || 0.1 || 670
 |-
 | {{tsl|en|Oxaprotiline||Oxaprotiline}} || 3,900 || 4.9 || 4,340 || 67,000 || 2,400 || 620 || 42,000 || ? || 21 || 2,900
|}

以上化合物於[[受体_(生物化学)|受體]]可能作為[[受体拮抗剂|受体拮抗剂]] (或[[反激动剂|反激动剂]]，視結合位點而定)，於[[膜上轉運蛋白|膜上轉運蛋白]]作為[[再攝取抑制劑|再攝取抑制劑]]。 

== 参考文献 ==
{{Reflist|30em}}

{{-}}
{{Antidepressants}}
{{Histaminergics}}
{{Serotonergics}}
{{Hypnotics and sedatives}}

[[Category:四环抗抑郁药|]]